Shmidt E., Levitt J. Dermatologic infestations // Int. J. Dermatol. 2012. Vol. 51. N. 2. P. 131–141.
Sidbury R., Davis D.M., Cohen D.E. et al. Guidelines of care for the management of atopic dermatitis, section 3: Management and treatment with phototherapy and systemic agents // J. Am. Acad. Dermatol. 2014. Vol. 71. N. 2. P. 327–349.
Sidbury R., Tom W.L., Bergman J.N. et al. Guidelines of care for the management of atopic dermatitis, section 4: Prevention of disease flares and use of adjunctive therapies and approaches // J. Am. Acad. Dermatol. 2014. Vol. 71. N. 6. P. 1218–1233.
Smith F.J.D., Irvine A.D., Terron-Kwiatkowski A. et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris // Nat. Genet. 2006. Vol. 38. N. 3. P. 337–342.
Suarez-Farinas M., Dhingra N., Gittler J. et al. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis // J. Allergy Clin. Immunol. 2013. Vol. 132. N. 2. P. 361–370.
Tavil B., Erdem A.Y., Azik F. et al. Successful allogeneic hemopoietic stem cell transplantation in a case of Wiskott-Aldrich syndrome and non-Hodgkin lymphoma // Pediatr. Transplant. 2013. Vol. 17. N. 6. P. E146–E148.
Thyssen J.P., Godoy-Gijon E., Elias P.M. Ichthyosis vulgaris: the filaggrin mutation disease // Br. J. Dermatol. 2013. Vol. 168. P. 1155–1166.
Tokura Y. Extrinsic and intrinsic types of atopic dermatitis // J. Dermatol. Sci. 2010. Vol. 58. N. 1. P. 1–7.
Tom W.L., Eichenfield L.F. Eczematous disorders // Neonatal and Infant Dermatology / Eds L.F. Eichenfield, I.J. Frieden, E.F. Mathes, A.L. Zaenglein. 3rd ed. Elsevier, 2015. P. 216–232.
Vasilopoulos Y., Sharaf N., di Giovine F. et al. The 3′-UTR AACCins5874 in the stratum corneum chymotryptic enzyme gene (SCCE/KLK7), associated with atopic dermatitis; causes an increased mRNA expression without altering its stability // J. Dermatol. Sci. 2011. Vol. 61. N. 2. P. 131–133.
Weidinger S., Beck L.A., Bieber T. et al. Atopic dermatitis // Nat. Rev. Dis. Prim. 2018. Vol. 4. P. 1.
Weidinger S., O’Sullivan M., Illig T. et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children // J. Allergy Clin. Immunol. 2008. Vol. 121. N. 5. P. 1203–1209.
Wollenberg A., Barbarot S., Bieber T. et al. Consensus-based European Guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I // J. Eur. Acad. Dermatol. Venereol. 2018. Vol. 32. N. 5. P. 657–682.
Wollenberg A., Barbarot S., Bieber T. et al. Consensus-based European Guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II // J. Eur. Acad. Dermatol. Venereol. 2018. Vol. 32. N. 6. P. 850–878.
Yang G., Seok J.K., Kang H.C. et al. Skin barrier abnormalities and immune dysfunction in atopic dermatitis // Int. J. Mol. Sci. 2020. Vol. 21. N. 8. P. 2867.
Zhang L.Y., Tian W., Shu L. et al. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in Mainland China // Scand. J. Immunol. 2013. Vol. 78. N. 3. P. 258–265.
Zhao L.P., Di Z., Zhang L. et al. Association of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China // J. Eur. Acad. Dermatol. Venereol. 2012. Vol. 26. N. 5. P. 572–577.
&hide_Cookie=yes)